UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
November 14, 2024
Accession Number:
0001213900-24-097459
Submission Type:
POS AM
CIK:
0001766140
Company Name:
Unicycive Therapeutics, Inc.
File Number:
333-266890